Cargando…

Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”

Detalles Bibliográficos
Autores principales: Speeckaert, Reinhart, Lambert, Jo, Puig, Lluís, Speeckaert, Marijn, Lapeere, Hilde, De Schepper, Sofie, van Geel, Nanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965843/
https://www.ncbi.nlm.nih.gov/pubmed/33744352
http://dx.doi.org/10.1016/j.jaad.2021.03.038
_version_ 1783665650262081536
author Speeckaert, Reinhart
Lambert, Jo
Puig, Lluís
Speeckaert, Marijn
Lapeere, Hilde
De Schepper, Sofie
van Geel, Nanja
author_facet Speeckaert, Reinhart
Lambert, Jo
Puig, Lluís
Speeckaert, Marijn
Lapeere, Hilde
De Schepper, Sofie
van Geel, Nanja
author_sort Speeckaert, Reinhart
collection PubMed
description
format Online
Article
Text
id pubmed-7965843
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-79658432021-03-17 Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology” Speeckaert, Reinhart Lambert, Jo Puig, Lluís Speeckaert, Marijn Lapeere, Hilde De Schepper, Sofie van Geel, Nanja J Am Acad Dermatol JAAD Online by the American Academy of Dermatology, Inc. 2021-08 2021-03-17 /pmc/articles/PMC7965843/ /pubmed/33744352 http://dx.doi.org/10.1016/j.jaad.2021.03.038 Text en © 2021 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle JAAD Online
Speeckaert, Reinhart
Lambert, Jo
Puig, Lluís
Speeckaert, Marijn
Lapeere, Hilde
De Schepper, Sofie
van Geel, Nanja
Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
title Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
title_full Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
title_fullStr Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
title_full_unstemmed Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
title_short Comment on “An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology”
title_sort comment on “an evidence-based guide to sars-cov-2 vaccination of patients on immunotherapies in dermatology”
topic JAAD Online
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7965843/
https://www.ncbi.nlm.nih.gov/pubmed/33744352
http://dx.doi.org/10.1016/j.jaad.2021.03.038
work_keys_str_mv AT speeckaertreinhart commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology
AT lambertjo commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology
AT puiglluis commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology
AT speeckaertmarijn commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology
AT lapeerehilde commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology
AT descheppersofie commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology
AT vangeelnanja commentonanevidencebasedguidetosarscov2vaccinationofpatientsonimmunotherapiesindermatology